http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012154771-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9096e1b537003a1257d893893116a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_148281609c07d843672ccfb7619725e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e6f7cb27560363ee6cc8f5fe65924c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f9e8b7b979588338471d2d4dfd9aa72 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
filingDate | 2012-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fbf88407090a7a04790fef1cb652147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f471c381cf2be47de803ab58240f39a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3febad71e1a3afb8d4c08e438c25d476 |
publicationDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2012154771-A1 |
titleOfInvention | Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder |
abstract | Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of extended release fesoterodine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder, the method comprising identifying a patient in need thereof, and administering to the patient a therapeutically effective amount of extended release fesoterodine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of alleviating a side effect of treatment for overactive bladder in a patient suffering therefrom, the method comprising identifying a patient in need thereof, and administering to the patient a therapeutically effective amount of extended release fesoterodine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof. |
priorityDate | 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.